Effects of deoxyadenosine (dAdo) and adenine arabinoside (AraA) during deoxycoformycin (dCF) therapy
Publication
, Journal Article
Hershfield, M; Kredich, N; Falletta, J
Published in: Proceedings of the American Association for Cancer Research
January 1, 1981
Duke Scholars
Published In
Proceedings of the American Association for Cancer Research
Publication Date
January 1, 1981
Volume
Vol. 22
Start / End Page
621
Citation
APA
Chicago
ICMJE
MLA
NLM
Hershfield, M., Kredich, N., & Falletta, J. (1981). Effects of deoxyadenosine (dAdo) and adenine arabinoside (AraA) during deoxycoformycin (dCF) therapy. Proceedings of the American Association for Cancer Research, Vol. 22, 621.
Hershfield, M., N. Kredich, and J. Falletta. “Effects of deoxyadenosine (dAdo) and adenine arabinoside (AraA) during deoxycoformycin (dCF) therapy.” Proceedings of the American Association for Cancer Research Vol. 22 (January 1, 1981): 621.
Hershfield M, Kredich N, Falletta J. Effects of deoxyadenosine (dAdo) and adenine arabinoside (AraA) during deoxycoformycin (dCF) therapy. Proceedings of the American Association for Cancer Research. 1981 Jan 1;Vol. 22:621.
Hershfield, M., et al. “Effects of deoxyadenosine (dAdo) and adenine arabinoside (AraA) during deoxycoformycin (dCF) therapy.” Proceedings of the American Association for Cancer Research, vol. Vol. 22, Jan. 1981, p. 621.
Hershfield M, Kredich N, Falletta J. Effects of deoxyadenosine (dAdo) and adenine arabinoside (AraA) during deoxycoformycin (dCF) therapy. Proceedings of the American Association for Cancer Research. 1981 Jan 1;Vol. 22:621.
Published In
Proceedings of the American Association for Cancer Research
Publication Date
January 1, 1981
Volume
Vol. 22
Start / End Page
621